Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ionotropic glutamate receptor ligands for neurological and CNS disorders

April 28, 1998

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Synthetic, nonandrogenic DHEA active in animal model of MS

April 28, 1998

New NK1 receptor antagonist ineffective against postherpetic neuralgia

April 27, 1998

Novo Nordisk sells Seroxat marketing rights to SKB

April 27, 1998

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Generic controlled-release carbamazepine approved in U.K.

April 27, 1998

OHM-3507: a fentanyl derivative with incongruent pharmacological effects

April 24, 1998

AChE inhibitors for Alzheimer's disease disclosed by Sagami

April 24, 1998

Positive phase III results reported for Neurobloc in cervical dystonia

April 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...